A Phase 2b double-blind, randomized, low-dose comparator-controlled clinical trial to assess the efficacy and safety of PEX010 in psilocybin-assisted psychotherapy for the treatment of adjustment disorder due to incurable cancer diagnosis
100 Clinical Results associated with Psyence Australia Pty Ltd.
0 Patents (Medical) associated with Psyence Australia Pty Ltd.
100 Deals associated with Psyence Australia Pty Ltd.
100 Translational Medicine associated with Psyence Australia Pty Ltd.